EXANE DERIVATIVES - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$148,000
-78.9%
5
-80.0%
0.00%
Q1 2022$703,000
-39.0%
250.0%0.00%
Q4 2021$1,152,000
+40.5%
250.0%0.00%
Q3 2021$820,000
-99.4%
25
-99.4%
0.00%
-100.0%
Q2 2021$146,540,000
+44989.2%
4,364
+48388.9%
0.03%
Q1 2021$325,000
-93.3%
9
-94.6%
0.00%
-100.0%
Q4 2020$4,849,0001670.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders